Pharm D Notes 📝📒

https://docs.google.com/forms/d/1YItukbfpgI3-1jpmI-N4SjdO9sXVqmIbdXmWoXjqSgI/edit

📌 FINAL REMAINDER HURRY UP!!
✨Don't Miss PHARMAVERGE DEMO AND CAREER GUIDANCE Session! ✨

Are you uncertain about your future career? Want clarity on your path to success? Don't miss PHARMAVERGE DEMO AND CAREER GUIDANCE Session!

🗓️ Date:05-01-2025
⌚ Time:3:30-4:30
🏢 Venue: Google meet
💲 Registration fee for Demo: FREE

Don't wait ! Your journey to success starts here
Join our community to connect with like-minded individuals, explore these opportunities, and reshape your future

Link:
https://meet.google.com/jfu-mywh-qjp
#pharmacy #pharmastudent #career #healthcare #tech #digitalhealth #clinicalresearch #medicalwriting #pharmamanagement@pharmDmaterials

Human metapneumovirus (hMPV) is a leading cause of acute respiratory infection. It was identified in 2001 by scientists in the Netherlands.

Key Facts:

Children, people with weakened immune systems and the elderly are most susceptible to developing complications from hMPV infection.
hPMV is spread by close contact with an infected individual or by coming in contact with a contaminated area.
hMPV usually causes symptoms similar to the common cold that last roughly 2-5 days and go away on their own.
Most children who get infected with hMPV are age 5 or younger. A small number of children (5-16%) infected will develop a lower respiratory tract infection such as pneumonia.

What Causes hMPV?
hMPV is most commonly spread from person to person through close contact with someone who is infected via secretions from coughing and sneezing or touching objects such as toys or doorknobs that have the virus on them. In the United States, hMPV is more likely to circulate during the winter and spring months when other similar infections, such as RSV and the flu, are prevalent.

Why to Choose us ?

👉 Registered Pharmacist
👉 Over 30+ successful registrations.
👉 If there are any document issues or other reasons for the application being rejected, we will reprocess it free of charge for a second time.

For more Details whatsapp us:
https://wa.me/message/24FHN3ODSHCUJ1

Manmohan Singh, former Indian PrimeMinister and the man behind the economic liberalisation that changed the economic graph of
the country, passed away on Thursday. He was 92.
He breathed his last at AllMS Delhi.

🌟 Revolutionizing Diabetes Care with Afrezza® 🌟

We are excited to share that Afrezza®, an ultra rapid-acting inhaled insulin, is now approved by CDSCO for distribution and marketing in India, thanks to Cipla's collaboration with MannKind Corporation.

Why Afrezza® is a Game-Changer:

Inhaled Convenience: Say goodbye to injections! Afrezza® is administered via an easy-to-use oral inhaler.

Rapid Action: Starts controlling blood sugar in just 12 minutes, thanks to its ultra rapid-acting insulin.

Flexibility: Available in 4-, 8-, and 12-unit color-coded cartridges for precise, customizable dosing.

Short Duration: Stops lowering blood glucose after 1.5–3 hours, offering flexibility for additional doses when needed.


Afrezza® empowers individuals with type 1 and type 2 diabetes to manage their blood sugar effectively while enjoying mealtime flexibility.

This innovative solution marks a significant milestone in diabetes care in India. Together, let’s embrace better health and improved quality of life!

JNTUA Pharm.D I Year Academic Calendar for Academic Year 2024-25 For 2024 Admitted Batch @ https://www.forum.universityupdates.in/threads/jntua-pharm-d-i-year-academic-calendar-for-academic-year-2024-25-for-2024-admitted-batch.49824/

Sir/Madam,
Warm Greetings from Seven Hills College of Pharmacy (Autonomous), Tirupati.

We are happy to inform you all that, Department of Pharmaceutics in association with Research & Development Cell & Institutions Innovation Cell (IIC), SHCP is organizing a Two day National Workshop on "Research Presentation Skills" on 26-12-2024 to 27-12-2024.

Venue: Prof. K. Chinnaswamy Auditorium, SHCP Campus

We request all Pharmacy professionals and others to actively register. The details are given below.

Link for registration: https://forms.gle/kKg4iSRHfog4Xeqw8
Registration Fee: Rs. 200/-
Payment Mode: Gpay to 7702484511

Your Attendance is mandatory to receive certificate. We wholeheartedly welcome you all for the National Workshop.

Regards
Convener
Dr. K. Saravanakumarr
Director (Academics)
Seven Hills College of Pharmacy (Autonomous), Tirupati

JNTUA Time Table for Pharm.D I, II, III, IV Years (R17, R14) Advanced Supplementary/Supplementary Exams - January 2025 @ https://www.forum.universityupdates.in/threads/jntua-time-table-for-pharm-d-i-ii-iii-iv-years-r17-r14-advanced-supplementary-supplementary-exams-january-2025.49827/

*Indegene Pharmacovigilance Openings* ❤️🔥

*Qualification: B.pharm, M.pharm, Msc, Bsc, Pharm.D, Lifesciences*

*Apply link 🖇️*
https://pharmabharat.com/indegene-hiring-in-pharmacovigilance-2/

https://www.linkedin.com/posts/drkarthikrakam_pharmd-opportunity-freshers-activity-7269230637465645057-lBZV?utm_source=screenshot_social_share&utm_medium=android_app&utm_campaign=copy_link

JNTUA Pharm.D 1st, 2nd, 3rd, 4th Year (R17, R14, R09) Advanced Supplementary/Supplementary Examinations Notification - January 2025 @ https://www.forum.universityupdates.in/threads/jntua-pharm-d-1st-2nd-3rd-4th-year-r17-r14-r09-advanced-supplementary-examinations-notification-january-2025.49773/

JNTUA Pharm.D (P.B) I, II Year (R17) Regular & Supplementary Examinations Results - August/September/October 2024 @ https://www.forum.universityupdates.in/threads/jntua-pharm-d-p-b-i-ii-year-r17-regular-supplementary-examinations-results-august-september-october-2024.49682/

*Dear sir/madam,*

*Greetings from School of Pharmaceutical Sciences, Sandip University, Nashik!!!*

We’re excited to invite you to our One-Week Online Training Program on:
*"Integrating Network Pharmacology with Traditional and Modern Systems of Medicine: Bridging Multi-System Therapeutics for Holistic Healthcare"*

*Dates:* 9th Dec – 14th Dec 2024.

*Time:* 10:30 AM – 12:00 Noon (IST)

*Registration Fee:* ₹300/-


*Key Highlights:*
✍️ *Network Pharmacology:* A modern approach to drug discovery
✍️ *Herbal Medicine + Modern Therapeutics:* Blending traditional remedies with contemporary treatments
✍️ *Multi-Target Approaches:* How traditional medicine affects multiple pathways
✍️ *Molecular Modelling:* Revolutionizing drug development with advanced tools.

*Key Benefits:*
👉e-Certificate of Completion.
👉End-to-End Technical Support with software.
👉Networking opportunities with top research institutes.
👉Access to exclusive training resources

*Registration link:* https://forms.gle/My1JeKLcvQr8AxsK9
*Payment link:* http://surl.li/lpfgqg
Looking forward to your participation!

Best regards,
*Dr. Mohan Gandhi Bonthu* (9866847074)
*Dr. Nagaraju Bandaru* (9603674173)
Organising Committee,
SOPS, Sandip University, Nashik.

JNTUA Recounting Results of Pharm.D II, III, IV Year (R17) Regular and Supplementary July/August/September 2024 Exams @ https://www.forum.universityupdates.in/threads/recounting-results-of-pharm-d-ii-year-r17-regular-supplementary-september-2024-exams.49678/

JNTUA Pharm.D I Year (R17) Regular & Supplementary Examinations Results - September/October 2024 @ https://www.forum.universityupdates.in/threads/jntua-pharm-d-i-year-r17-regular-supplementary-examinations-results-september-october-2024.49651/

*Cliantha Research Hiring in CDM, SAS, Medical Writer, Clinical Trials, Buisness development* ✅🔥

*Qualification: B.pharm, M.pharm, Msc, Pharm.D, Lifesciences, MBA*

*Apply link 🖇️*
https://pharmabharat.com/cliantha-research-hiring-in-cdm-sas-medical-writer-clinical-trials-buisness-development/

*Join our FREE Webinar!*

🔬 *Clinical Research in the UK*
*Unlocking a High-Demand Career for Life Sciences Professionals*

📅 *Date:* 23rd November
⏰ *Time:* 5:00 PM to 6:00 PM (IST)

*Speaker:* Dr. Tejaswini, Pharm. D | MSc Pharmacology (UK)
- Senior Clinical Trials Coordinator in NHS Cancer Research

*Q&A Session by:* Dr. Mahesh Arandula, B. Pharm | Pharm. D | MS in Italy

🎤 *Hosted by:* Shiny Winslet

Don't miss this opportunity to explore a thriving career path in clinical research!

📲 *Register Now!* : https://forms.gle/v6xayS9vZ6nJg49JA

For more details, contact us at:
📞 +91 96661 63536, +91 81061 71222
📧 crystal_overseas_hyderabad

Here are some useful tools for producing a Research or Review Article 👇👇👇
1.Quill bot for paraphrase
Grammarly for grammar corrections
2.HIX bypass to humanise
Zerogpt for AI dectection
3.Plagiarism detector.net for plagiarism check
4.Humbot.ai to humanise AI generated content

JNTUA RC, CV & PCA Notification for Pharm.D II, III, IV Year (R17, R14) Regular & Supplementary Examinations Results - July/August/September 2024 @ https://www.forum.universityupdates.in/threads/jntua-rc-cv-pca-notification-for-pharm-d-ii-iii-iv-year-r17-r14-regular-supplementary-examinations-results-july-august-september-2024.49365/

JNTUA Pharm.D II, III, IV Year (R17, R14) Regular & Supplementary Examinations Results - July/August/September 2024 @ https://www.forum.universityupdates.in/threads/jntua-pharm-d-ii-iii-iv-year-r17-r14-regular-supplementary-examinations-results-july-august-september-2024.49349/

Andhra Pradesh Pharmacy Council is shifting to Vijayawada (Address: Regional Drug store building, First floor, Siddhartha Medical College Compound, NH 16 service road, Gunadala, Vijayawada, NTR District - 520008.)

Hence those who have booked the slot dates from 01.11.024 to 08.11.2024 are requested to come to the office between 12.11.2024 to 12.12.2024 on any working day during office hours for verification of certificates and documents at Andhra Pradesh Pharmacy Council, office, Regional Drug store building, 1st floor, Siddhartha Medical College Compound, NH 16 Service Road, Gunadala, Vijayawada, NTR District - 520008.

With Regards,
Registrar,
A.P.Pharmacy Council
Guntur.
Phone:08632224524.

Several notable drugs have been recently approved in 2024, bringing advancements in treatments across various conditions. Key updates include:

1. Cobenfy (xanomeline and trospium chloride), approved for schizophrenia, being a first-in-class muscarinic agonist.
2. Aqneursa (levacetylleucine), for Niemann-Pick disease type C.
3. Ebglyss (lebrikizumab-lbkz), an IL-13 inhibitor for moderate-to-severe atopic dermatitis.
4. Tecentriq Hybreza (atezolizumab and hyaluronidase), a cancer immunotherapy targeting PD-L1 for lung cancer, melanoma.

*Join Us for Another Exciting Webinar!*

ClinoSol Research, in collaboration with the Indian Pharmaceutical Association and the Indian Pharmaceutical Association Students' Forum, invites you to join our upcoming webinar!

*Topic: "Adoption and Impact of Technology on Clinical Operations"*

📅 Date: 26th October 2024
🕕 Time: 6:00 PM (IST)

🎙️ Expert Speakers:

Dr. Siew Lee Goh – Director, Patient Recruitment & Retention Management, Syneos Health, Singapore
Abhishek Tyagi – Senior Director, FSP Hub Lead India
Suhail Ali – Vice President & Head, Clinical Delivery APAC, ICON
Dr. Sridhar Yeshamaina – Artificial Intelligence Scientist, Boston University, USA
Mujeebuddin Shaik – Founder & CEO, ClinoSol Research

*Free Registration + Participation Certificate*

📝 Register Now: https://forms.gle/74K8fMrAnp3GxKoj9
💬 Join the WhatsApp Group: https://chat.whatsapp.com/KWTsOn33YMvJsIJsEUuZ8O

Don’t miss this opportunity to gain insights from industry experts on how technology is transforming clinical operations. See you there!

Best Regards,
Team ClinoSol

https://webjapps.ias.ac.in/fellowship2025/application_instructions.jsp

JNTUA Pharm D 2nd year Question papers September 2024 Regular and supplementary